These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 9706876)
1. Intermittent administration of parathyroid hormone (1-34) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone. McClelland P; Onyia JE; Miles RR; Tu Y; Liang J; Harvey AK; Chandrasekhar S; Hock JM; Bidwell JP J Cell Biochem; 1998 Sep; 70(3):391-401. PubMed ID: 9706876 [TBL] [Abstract][Full Text] [Related]
2. In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. Onyia JE; Miles RR; Yang X; Halladay DL; Hale J; Glasebrook A; McClure D; Seno G; Churgay L; Chandrasekhar S; Martin TJ J Bone Miner Res; 2000 May; 15(5):863-71. PubMed ID: 10804015 [TBL] [Abstract][Full Text] [Related]
3. Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor. Kulkarni NH; Wei T; Kumar A; Dow ER; Stewart TR; Shou J; N'cho M; Sterchi DL; Gitter BD; Higgs RE; Halladay DL; Engler TA; Martin TJ; Bryant HU; Ma YL; Onyia JE J Cell Biochem; 2007 Dec; 102(6):1504-18. PubMed ID: 17520664 [TBL] [Abstract][Full Text] [Related]
4. Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone. Pettway GJ; Schneider A; Koh AJ; Widjaja E; Morris MD; Meganck JA; Goldstein SA; McCauley LK Bone; 2005 Jun; 36(6):959-70. PubMed ID: 15878317 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Ries C; Loher F; Zang C; Ismair MG; Petrides PE Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746 [TBL] [Abstract][Full Text] [Related]
6. Identification of a PTH regulated gene selectively induced in vivo during PTH-mediated bone formation. Robinson JA; Susulic V; Liu YB; Taylor C; Hardenburg J; Gironda V; Zhao W; Kharode Y; McLarney S; Bai Y; Malone DP; Murrills R; Bex F J Cell Biochem; 2006 Aug; 98(5):1203-20. PubMed ID: 16514668 [TBL] [Abstract][Full Text] [Related]
7. PGE2 induces the gene expression of bone matrix metalloproteinase-1 in mouse osteoblasts by cAMP-PKA signaling pathway. Kim CH; Park YG; Noh SH; Kim YK Int J Biochem Cell Biol; 2005 Feb; 37(2):375-85. PubMed ID: 15474982 [TBL] [Abstract][Full Text] [Related]
8. Differential regulation of MMP-13 by chemical modified tetracyclines in osteoblasts. Kirkwood K; Martin T; Agnello K; Kim YJ J Int Acad Periodontol; 2004 Apr; 6(2):39-46. PubMed ID: 15125014 [TBL] [Abstract][Full Text] [Related]
9. The influence of an in vitro generated bone-like extracellular matrix on osteoblastic gene expression of marrow stromal cells. Pham QP; Kasper FK; Scott Baggett L; Raphael RM; Jansen JA; Mikos AG Biomaterials; 2008 Jun; 29(18):2729-39. PubMed ID: 18367245 [TBL] [Abstract][Full Text] [Related]
10. Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases. Parikka V; Väänänen A; Risteli J; Salo T; Sorsa T; Väänänen HK; Lehenkari P Matrix Biol; 2005 Sep; 24(6):438-47. PubMed ID: 16098718 [TBL] [Abstract][Full Text] [Related]
11. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398 [TBL] [Abstract][Full Text] [Related]
12. Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. Locklin RM; Khosla S; Turner RT; Riggs BL J Cell Biochem; 2003 May; 89(1):180-90. PubMed ID: 12682918 [TBL] [Abstract][Full Text] [Related]
13. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Rickard DJ; Wang FL; Rodriguez-Rojas AM; Wu Z; Trice WJ; Hoffman SJ; Votta B; Stroup GB; Kumar S; Nuttall ME Bone; 2006 Dec; 39(6):1361-72. PubMed ID: 16904389 [TBL] [Abstract][Full Text] [Related]
14. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542 [TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis and localization of mRNA transcripts of type I collagen, osteocalcin, MMP 2, MMP 8, and MMP 13 during bone healing in a rat calvarial experimental defect model. Itagaki T; Honma T; Takahashi I; Echigo S; Sasano Y Anat Rec (Hoboken); 2008 Aug; 291(8):1038-46. PubMed ID: 18615687 [TBL] [Abstract][Full Text] [Related]
16. SOST is a target gene for PTH in bone. Keller H; Kneissel M Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of G11alpha in osteoblastic cells enhances parathyroid hormone activation of phospholipase C and AP-1 regulation of matrix metalloproteinase-13 mRNA. Cheung R; Erclik MS; Mitchell J J Cell Physiol; 2005 Jul; 204(1):336-43. PubMed ID: 15693018 [TBL] [Abstract][Full Text] [Related]